Yew Bio-Pharm Group, Inc. Value Added Tax Receivable, Current
Yew Bio-Pharm Group, Inc. had Value Added Tax Receivable, Current of $53.56 thousand as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Notes › Receivables › Nontrade Receivables
us-gaap:ValueAddedTaxReceivableCurrent · last filed 2021-11-15
- 2021-09-30: Value Added Tax Receivable, Current $53.56K.
- 2021-06-30: Value Added Tax Receivable, Current $267.99K.
- 2021-03-31: Value Added Tax Receivable, Current $350.42K.
- 2020-12-31: Value Added Tax Receivable, Current $56.64K.
| Period end | Value Added Tax Receivable, Current |
|---|---|
| 2021-09-30 | $53.56K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $267.99K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $350.42K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $56.64K 10-Q · filed 2021-11-15 |
| 2020-09-30 | $367.08K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $751.87K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $343.52K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $349.10K 10-K · filed 2021-03-30 |
| 2019-09-30 | $56.19K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.17M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.01M 10-Q · filed 2019-05-22 |
| 2018-12-31 | $985.83K 10-K · filed 2020-05-14 |
| 2018-09-30 | $1.06M 10-Q · filed 2018-11-19 |
| 2018-06-30 | $990.40K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $409.19K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $170.56K 10-K · filed 2019-05-07 |
| 2017-09-30 | $622.13K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $1.40M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.25M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $1.66M 10-K · filed 2018-04-02 |
| 2016-09-30 | $2.55M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $2.35M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $801.39K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $699.26K 10-K · filed 2017-03-31 |
| 2015-09-30 | $1.07M 10-Q · filed 2015-11-16 |